Blackstone Selling BioMed in a Deal Worth $14.6 Billion

Leading company in real estate investing Blackstone Real Estate Partners announced that together with its co-investors they have discussed and resolved to sell self-administered and self-managed real estate investment company BioMed Realty Trust Inc. (BMR) for a price of $14.6 billion.

Blackstone will be selling the entity to a group led by existing investors in BioMed Realty.

Blackstone purchased the company five years ago while it was still a supplier of office space to healthcare companies in a deal worth $8 billion.

Blackstone said anytime soon it will be starting a ‘go-shop’ process for the benefit of current investors of BioMed Realty thereafter, recapitalization will take place five business days after the process has wrapped up.

Leave a comment

Your email address will not be published. Required fields are marked *